Treatment of COVID-19 ARDS with a tabletop NIV device in a Respiratory Intermediate Care Unit
B. Isaac (Vellore (Tamil Nadu), India), N. Priya (Vellore (Tamil Nadu), India), A. Nair (Vellore (Tamil Nadu), India), B. Thangakunam (Vellore (Tamil Nadu), India), A. Balachandran (Vellore (Tamil Nadu), India), T. George (Vellore (Tamil Nadu), India), S. Thomas (Vellore (Tamil Nadu), India), T. George (Vellore (Tamil Nadu), India), R. Iyadurai (Vellore (Tamil Nadu), India), S. Kumar (Vellore (Tamil Nadu), India), A. Zachariah (Vellore (Tamil Nadu), India), B. Singh (Vellore (Tamil Nadu), India), P. Rupali (Vellore (Tamil Nadu), India), K. Pichamuthu (Vellore (Tamil Nadu), India), R. Gupta (Vellore (Tamil Nadu), India), J. Daniel (Vellore (Tamil Nadu), India), J. Roger (Vellore (Tamil Nadu), India), S. Chandy (Vellore (Tamil Nadu), India), D. Christopher (Vellore (Tamil Nadu), India)
Source: International Congress 2022 – Noninvasive respiratory support in COVID-19: what did we learn?
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Isaac (Vellore (Tamil Nadu), India), N. Priya (Vellore (Tamil Nadu), India), A. Nair (Vellore (Tamil Nadu), India), B. Thangakunam (Vellore (Tamil Nadu), India), A. Balachandran (Vellore (Tamil Nadu), India), T. George (Vellore (Tamil Nadu), India), S. Thomas (Vellore (Tamil Nadu), India), T. George (Vellore (Tamil Nadu), India), R. Iyadurai (Vellore (Tamil Nadu), India), S. Kumar (Vellore (Tamil Nadu), India), A. Zachariah (Vellore (Tamil Nadu), India), B. Singh (Vellore (Tamil Nadu), India), P. Rupali (Vellore (Tamil Nadu), India), K. Pichamuthu (Vellore (Tamil Nadu), India), R. Gupta (Vellore (Tamil Nadu), India), J. Daniel (Vellore (Tamil Nadu), India), J. Roger (Vellore (Tamil Nadu), India), S. Chandy (Vellore (Tamil Nadu), India), D. Christopher (Vellore (Tamil Nadu), India). Treatment of COVID-19 ARDS with a tabletop NIV device in a Respiratory Intermediate Care Unit. 4239
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|